sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Category : Pharmaceuticals and Healthcare QY Research Pages :128
Published Date : 2018-11-01

 

This report studies the global Spinal Muscular Atrophy Medicine market status and forecast, categorizes the global Spinal Muscular Atrophy Medicine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Astellas Pharma Inc. AveXis, Inc. Bioblast Pharma Ltd. Cytokinetics, Inc. 24 F. Hoffmann-La Roche Ltd. Genethon Genzyme Corporation GMP-Orphan SAS Ionis Pharmaceuticals, Inc. Longevity Biotech, Inc Neurodyn Inc. Neurotune AG Novartis AG Sarepta Therapeutics, Inc. Voyager Therapeutics, Inc. Vybion, Inc. WAVE Life Sciences Ltd. Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan Southeast Asia India We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into LMI-070 ND-602 NT-1654 Nusinersen NXD-30001 Others On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Hospital Clinic Others The study objectives of this report are: To analyze and study the global Spinal Muscular Atrophy Medicine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Spinal Muscular Atrophy Medicine manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Spinal Muscular Atrophy Medicine are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Spinal Muscular Atrophy Medicine Manufacturers Spinal Muscular Atrophy Medicine Distributors/Traders/Wholesalers Spinal Muscular Atrophy Medicine Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Spinal Muscular Atrophy Medicine market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global Spinal Muscular Atrophy Medicine Market Research Report 2018 1 Spinal Muscular Atrophy Medicine Market Overview 1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine 1.2 Spinal Muscular Atrophy Medicine Segment by Type (Product Category) 1.2.1 Global Spinal Muscular Atrophy Medicine Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 1.2.2 Global Spinal Muscular Atrophy Medicine Production Market Share by Type (Product Category) in 2017 1.2.3 LMI-070 1.2.3 ND-602 1.2.5 NT-1654 1.2.6 Nusinersen 1.2.7 NXD-30001 Others 1.3 Global Spinal Muscular Atrophy Medicine Segment by Application 1.3.1 Spinal Muscular Atrophy Medicine Consumption (Sales) Comparison by Application (2013-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Spinal Muscular Atrophy Medicine Market by Region (2013-2025) 1.4.1 Global Spinal Muscular Atrophy Medicine Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 1.4.2 North America Status and Prospect (2013-2025) 1.4.3 Europe Status and Prospect (2013-2025) 1.4.4 China Status and Prospect (2013-2025) 1.4.5 Japan Status and Prospect (2013-2025) 1.4.6 Southeast Asia Status and Prospect (2013-2025) 1.4.7 India Status and Prospect (2013-2025) 1.5 Global Market Size (Value) of Spinal Muscular Atrophy Medicine (2013-2025) 1.5.1 Global Spinal Muscular Atrophy Medicine Revenue Status and Outlook (2013-2025) 1.5.2 Global Spinal Muscular Atrophy Medicine Capacity, Production Status and Outlook (2013-2025) 2 Global Spinal Muscular Atrophy Medicine Market Competition by Manufacturers 2.1 Global Spinal Muscular Atrophy Medicine Capacity, Production and Share by Manufacturers (2013-2018) 2.1.1 Global Spinal Muscular Atrophy Medicine Capacity and Share by Manufacturers (2013-2018) 2.1.2 Global Spinal Muscular Atrophy Medicine Production and Share by Manufacturers (2013-2018) 2.2 Global Spinal Muscular Atrophy Medicine Revenue and Share by Manufacturers (2013-2018) 2.3 Global Spinal Muscular Atrophy Medicine Average Price by Manufacturers (2013-2018) 2.4 Manufacturers Spinal Muscular Atrophy Medicine Manufacturing Base Distribution, Sales Area and Product Type 2.5 Spinal Muscular Atrophy Medicine Market Competitive Situation and Trends 2.5.1 Spinal Muscular Atrophy Medicine Market Concentration Rate 2.5.2 Spinal Muscular Atrophy Medicine Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Spinal Muscular Atrophy Medicine Capacity, Production, Revenue (Value) by Region (2013-2018) 3.1 Global Spinal Muscular Atrophy Medicine Capacity and Market Share by Region (2013-2018) 3.2 Global Spinal Muscular Atrophy Medicine Production and Market Share by Region (2013-2018) 3.3 Global Spinal Muscular Atrophy Medicine Revenue (Value) and Market Share by Region (2013-2018) 3.4 Global Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.5 North America Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.6 Europe Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.7 China Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.8 Japan Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.9 Southeast Asia Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 3.10 India Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 4 Global Spinal Muscular Atrophy Medicine Supply (Production), Consumption, Export, Import by Region (2013-2018) 4.1 Global Spinal Muscular Atrophy Medicine Consumption by Region (2013-2018) 4.2 North America Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018) 4.3 Europe Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018) 4.4 China Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018) 4.5 Japan Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018) 4.6 Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018) 4.7 India Spinal Muscular Atrophy Medicine Production, Consumption, Export, Import (2013-2018) 5 Global Spinal Muscular Atrophy Medicine Production, Revenue (Value), Price Trend by Type 5.1 Global Spinal Muscular Atrophy Medicine Production and Market Share by Type (2013-2018) 5.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2013-2018) 5.3 Global Spinal Muscular Atrophy Medicine Price by Type (2013-2018) 5.4 Global Spinal Muscular Atrophy Medicine Production Growth by Type (2013-2018) 6 Global Spinal Muscular Atrophy Medicine Market Analysis by Application 6.1 Global Spinal Muscular Atrophy Medicine Consumption and Market Share by Application (2013-2018) 6.2 Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2013-2018) 6.3 Market Drivers and Opportunities 6.3.1 Potential Applications 6.3.2 Emerging Markets/Countries 7 Global Spinal Muscular Atrophy Medicine Manufacturers Profiles/Analysis 7.1 Astellas Pharma Inc. 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.1.4 Main Business/Business Overview 7.2 AveXis, Inc. 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.2.4 Main Business/Business Overview 7.3 Bioblast Pharma Ltd. 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.3.4 Main Business/Business Overview 7.4 Cytokinetics, Inc. 24 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.4.4 Main Business/Business Overview 7.5 F. Hoffmann-La Roche Ltd. 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 7.5.4 Main Business/Business Overview 7.6 Genethon 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Genethon Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.6.4 Main Business/Business Overview 7.7 Genzyme Corporation 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.7.4 Main Business/Business Overview 7.8 GMP-Orphan SAS 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.8.4 Main Business/Business Overview 7.9 Ionis Pharmaceuticals, Inc. 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.9.4 Main Business/Business Overview 7.8 Longevity Biotech, Inc 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.10.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 7.10.2.1 Product A 7.10.2.2 Product B 7.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 7.10.4 Main Business/Business Overview 7.11 Neurodyn Inc. 7.12 Neurotune AG 7.13 Novartis AG 7.14 Sarepta Therapeutics, Inc. 7.15 Voyager Therapeutics, Inc. 7.16 Vybion, Inc. 7.17 WAVE Life Sciences Ltd. 8 Spinal Muscular Atrophy Medicine Manufacturing Cost Analysis 8.1 Spinal Muscular Atrophy Medicine Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 9.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis 9.2 Upstream Raw Materials Sourcing 9.3 Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017 9.4 Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List 11 Market Effect Factors Analysis 11.1 Technology Progress/Risk 11.1.1 Substitutes Threat 11.1.2 Technology Progress in Related Industry 11.2 Consumer Needs/Customer Preference Change 11.3 Economic/Political Environmental Change 12 Global Spinal Muscular Atrophy Medicine Market Forecast (2018-2025) 12.1 Global Spinal Muscular Atrophy Medicine Capacity, Production, Revenue Forecast (2018-2025) 12.1.1 Global Spinal Muscular Atrophy Medicine Capacity, Production and Growth Rate Forecast (2018-2025) 12.1.2 Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025) 12.1.3 Global Spinal Muscular Atrophy Medicine Price and Trend Forecast (2018-2025) 12.2 Global Spinal Muscular Atrophy Medicine Production, Consumption , Import and Export Forecast by Region (2018-2025) 12.2.1 North America Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.2 Europe Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.3 China Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.4 Japan Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.5 Southeast Asia Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.2.6 India Spinal Muscular Atrophy Medicine Production, Revenue, Consumption, Export and Import Forecast (2018-2025) 12.3 Global Spinal Muscular Atrophy Medicine Production, Revenue and Price Forecast by Type (2018-2025) 12.4 Global Spinal Muscular Atrophy Medicine Consumption Forecast by Application (2018-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

Get Free Sample

List of Tables and Figures Figure Picture of Spinal Muscular Atrophy Medicine Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Spinal Muscular Atrophy Medicine Production Market Share by Types (Product Category) in 2017 Figure Product Picture of LMI-070 Table Major Manufacturers of LMI-070 Figure Product Picture of ND-602 Table Major Manufacturers of ND-602 Figure Product Picture of NT-1654 Table Major Manufacturers of NT-1654 Figure Product Picture of Nusinersen Table Major Manufacturers of Nusinersen Figure Product Picture of NXD-30001 Table Major Manufacturers of NXD-30001 Figure Product Picture of Others Table Major Manufacturers of Others Figure Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) by Applications (2013-2025) Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Others Examples Table Key Downstream Customer in Others Figure Global Spinal Muscular Atrophy Medicine Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2013-2025) Figure North America Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Status and Outlook (2013-2025) Figure Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs) Status and Outlook (2013-2025) Figure Global Spinal Muscular Atrophy Medicine Major Players Product Capacity (K Pcs) (2013-2018) Table Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Key Manufacturers (2013-2018) Table Global Spinal Muscular Atrophy Medicine Capacity Market Share of Key Manufacturers (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Key Manufacturers in 2017 Figure Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Key Manufacturers in 2018 Figure Global Spinal Muscular Atrophy Medicine Major Players Product Production (K Pcs) (2013-2018) Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) of Key Manufacturers (2013-2018) Table Global Spinal Muscular Atrophy Medicine Production Share by Manufacturers (2013-2018) Figure 2017 Spinal Muscular Atrophy Medicine Production Share by Manufacturers Figure 2017 Spinal Muscular Atrophy Medicine Production Share by Manufacturers Figure Global Spinal Muscular Atrophy Medicine Major Players Product Revenue (Million USD) (2013-2018) Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Manufacturers (2013-2018) Table Global Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers (2013-2018) Table 2017 Global Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers Table 2018 Global Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers Table Global Market Spinal Muscular Atrophy Medicine Average Price (USD/Pcs) of Key Manufacturers (2013-2018) Figure Global Market Spinal Muscular Atrophy Medicine Average Price (USD/Pcs) of Key Manufacturers in 2017 Table Manufacturers Spinal Muscular Atrophy Medicine Manufacturing Base Distribution and Sales Area Table Manufacturers Spinal Muscular Atrophy Medicine Product Category Figure Spinal Muscular Atrophy Medicine Market Share of Top 3 Manufacturers Figure Spinal Muscular Atrophy Medicine Market Share of Top 5 Manufacturers Table Global Spinal Muscular Atrophy Medicine Capacity (K Pcs) by Region (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Capacity Market Share by Region (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Capacity Market Share by Region (2013-2018) Figure 2017 Global Spinal Muscular Atrophy Medicine Capacity Market Share by Region Table Global Spinal Muscular Atrophy Medicine Production by Region (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) by Region (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Production Market Share by Region (2013-2018) Figure 2017 Global Spinal Muscular Atrophy Medicine Production Market Share by Region Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Region (2013-2018) Table Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region (2013-2018) Table 2017 Global Spinal Muscular Atrophy Medicine Revenue Market Share by Region Figure Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs) and Growth Rate (2013-2018) Table Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table North America Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table Europe Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table China Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table Japan Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table Southeast Asia Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table India Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Market by Region (2013-2018) Table Global Spinal Muscular Atrophy Medicine Consumption Market Share by Region (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Region (2013-2018) Figure 2017 Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Market Share by Region Table North America Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018) Table Europe Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018) Table China Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018) Table Japan Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018) Table Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018) Table India Spinal Muscular Atrophy Medicine Production, Consumption, Import & Export (K Pcs) (2013-2018) Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) by Type (2013-2018) Table Global Spinal Muscular Atrophy Medicine Production Share by Type (2013-2018) Figure Production Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018) Figure 2017 Production Market Share of Spinal Muscular Atrophy Medicine by Type Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) by Type (2013-2018) Table Global Spinal Muscular Atrophy Medicine Revenue Share by Type (2013-2018) Figure Production Revenue Share of Spinal Muscular Atrophy Medicine by Type (2013-2018) Figure 2017 Revenue Market Share of Spinal Muscular Atrophy Medicine by Type Table Global Spinal Muscular Atrophy Medicine Price (USD/Pcs) by Type (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Production Growth by Type (2013-2018) Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) by Application (2013-2018) Table Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Applications (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application in 2017 Table Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2013-2018) Figure Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2013-2018) Table Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table AveXis, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table AveXis, Inc. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Bioblast Pharma Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Cytokinetics, Inc. 24 Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Genethon Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Genethon Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Genethon Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Genethon Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Genethon Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Genzyme Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Genzyme Corporation Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table GMP-Orphan SAS Basic Information, Manufacturing Base, Sales Area and Its Competitors Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Longevity Biotech, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Growth Rate (2013-2018) Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Market Share (2013-2018) Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Market Share (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Spinal Muscular Atrophy Medicine Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis Table Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017 Table Major Buyers of Spinal Muscular Atrophy Medicine Table Distributors/Traders List Figure Global Spinal Muscular Atrophy Medicine Capacity, Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Price (Million USD) and Trend Forecast (2018-2025) Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) Forecast by Region (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Production Market Share Forecast by Region (2018-2025) Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Forecast by Region (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share Forecast by Region (2018-2025) Figure North America Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure North America Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table North America Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Asia-Pacific Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025) Figure Europe Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure Europe Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Europe Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025) Figure Central & South America Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure Central & South America Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Central & South America Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025) Figure Southeast Asia Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025) Figure India Spinal Muscular Atrophy Medicine Production (K Pcs) and Growth Rate Forecast (2018-2025) Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table India Spinal Muscular Atrophy Medicine Production, Consumption, Export and Import (K Pcs) Forecast (2018-2025) Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) Forecast by Type (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) Forecast by Type (2018-2025) Table Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Type (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2018-2025) Table Global Spinal Muscular Atrophy Medicine Price Forecast by Type (2018-2025) Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Forecast by Application (2018-2025) Figure Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Source

Get Free Sample

Related Reports

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Spinal Muscular Atrophy Medicine Market Research Report 2018

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)